Meningococcal ACWY (MenACWY) vaccination programme

Documents relating to the new meningococcal ACWY (MenACWY) vaccination programme.

Meningococcal disease is caused by invasive infection with the bacterium Neisseria meningitidis, also known as the meningococcus.

There are 12 identified capsular groups of which groups B, C, W and Y were historically the most common in the UK.

The MenACWY vaccine is being introduced in response to an increase in cases of invasive meningococcal disease capsular group W (MenW) disease.

This vaccine will provide direct protection to the vaccinated cohort and, by reducing carriage of MenW, will also provide indirect protection to unvaccinated children and adults.

Data and reports on the uptake of the MenACWY vaccine for England are published by PHE.

Immunisation patient group direction (PGD) templates are available for authorisation and adoption to provide NHS routine immunisation services.


Training for healthcare professionals

Posters and leaflets

Programme documents

Published 26 June 2015
Last updated 26 November 2018 + show all updates
  1. Added Meningococcal vaccination: statement from JCVI and Meningitis: signs and symptoms leaflet for university students.
  2. Added the combined Meningococcal disease: guidance on public health management to the collection.
  3. Added MenACWY: school leaver flyer.
  4. Latest guidance on the prevention and management of meningitis and septicaemia in higher education institutions.
  5. Added information for first time university entrants.
  6. Information and training slides added for healthcare professionals
  7. First published.